Lactoferrin as potential preventative and adjunct treatment for COVID-19
Raymond Chang, Tzi Bun Ng, Wei-Zen Sun
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.106118
The coronavirus disease 2019 (COVID-19) pandemic is rapidly advancing across the globe despite drastic public and personal health measures. Antivirals and nutritional supplements have been proposed as potentially useful against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes COVID-19, but few have been clinically established. Lactoferrin (Lf) is a naturally occurring, non-toxic glycoprotein that is orally available as a nutritional supplement and has established in vitro antiviral efficacy against a wide range of viruses, including SARS-CoV, a closely related coronavirus to SARS-CoV-2. Furthermore, Lf possesses unique immunomodulatory and anti-inflammatory effects that may be especially relevant to the pathophysiology of severe COVID-19 cases. Here we review the underlying biological mechanisms of Lf as an antiviral and immune regulator, and propose its unique potential as a preventative and adjunct treatment for COVID-19. We hope that further research and development of Lf nutritional supplementation would establish its role for COVID-19.
Competing interests: None declared. Ethical approval: Not required.
References
Andersen, Jenssen, Sandvik, Gutteberg, Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface, J Med Virol,
doi:10.1002/jmv.20171Baveye, Elass, Mazurier, Spik, Legrand, Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process, Clin Chem Lab Med,
doi:10.1515/CCLM.1999.049Behrens, Koretzky, Review: cytokine storm syndrome: looking toward the precision medicine era, Arthritis Rheumatol,
doi:10.1002/art.40071Bone, Balk, Cerra, Dellinger, Fein et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,
doi:10.1378/chest.101.6.1644Bruni, Capucchio, Biasibetti, Pessione, Cirrincione et al., Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine, Molecules,
doi:10.3390/molecules21060752Calina, Docea, Petrakis, Egorov, Ishmukhametov et al., Towards effective COVID-19 vaccines: updates, perspectives and challenges (review), Int J Mol Med,
doi:10.3892/ijmm.2020.4596Chen, Liu, Guo, Emerging coronaviruses: genome structure, replication, and pathogenesis, J Med Virol,
doi:10.1002/jmv.25681Egashira, Takayanagi, Moriuchi, Moriuchi, Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis, Acta Paediatr,
doi:10.1111/j.1651-2227.2007.00393.xFung, Yuen, Ye, Chan, Jin, A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses, Emerg Microbes Infect,
doi:10.1080/22221751.2020.1736644Guntupalli, Dean, Morris, Bandi, Margolis et al., A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis, Crit Care Med,
doi:10.1097/CCM.0b013e3182741551Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell,
doi:10.1016/j.cell.2020.02.052Hong, Wang, Chung, Chen, Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children, Pediatr Neonatol,
doi:10.1016/j.pedneo.2020.03.001Ishikado, Imanaka, Takeuchi, Harada, Makino, Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration, Biol Pharm Bull,
doi:10.1248/bpb.28.1717Kaito, Iwasa, Fujita, Kobayashi, Kojima et al., Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin, J Gastroenterol Hepatol,
doi:10.1111/j.1440-1746.2007.04858.xKruzel, Actor, Radak, Bacsi, Saavedra-Molina et al., Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model, Innate Immun,
doi:10.1177/1753425909105317Kruzel, Harari, Chen, Castro, Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice, Inflammation,
doi:10.1023/a:1006935908960Lang, Yang, Deng, Liu, Yang et al., Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans, PLoS One,
doi:10.1371/journal.pone.0023710Legrand, Elass, Carpentier, Mazurier, Interactions of lactoferrin with cells involved in immune function, Biochem Cell Biol,
doi:10.1139/o06-045Levay, Viljoen, Lactoferrin: a general review, Haematologica
Lu, Hangoc, Oliff, Chen, Shen et al., Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex, Cancer Res
Marchetti, Superti, Ammendolia, Rossi, Valenti et al., Inhibition of poliovirus type 1 infection by iron-, manganese-and zincsaturated lactoferrin, Med Microbiol Immunol,
doi:10.1007/s004300050093Mehta, Mcauley, Brown, Sanchez, Tattersall et al., Across Speciality Collaboration. COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet,
doi:10.1016/S0140-6736(20)30628-0Milewska, Zarebski, Nowak, Stozek, Potempa et al., Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells, J Virol,
doi:10.1128/jvi.02078-14Nozaki, Ikeda, Naganuma, Nakamura, Inudoh et al., Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein, J Biol Chem,
doi:10.1074/jbc.M207879200Oda, Nakano, Wakabayashi, Yamauchi, Toida et al., Questionnaire survey on the subjective effects of a lactoferrin supplement, J Jpn Soc Complement Altern Med,
doi:10.1625/jcam.9.121Puddu, Borghi, Gessani, Valenti, Belardelli et al., Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection, Int J Biochem Cell Biol,
doi:10.1016/s1357-2725(98)00066-1Razak, Hussain, Lactoferrin supplementation to prevent late-onset sepsis in preterm infants: a meta-analysis, Am J Perinatol,
doi:10.1055/s-0039-1696676Rosa, Cutone, Lepanto, Paesano, Valenti, Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis, Int J Mol Sci,
doi:10.3390/ijms18091985Serrano, Kochergina, Albors, Diaz, Oroval et al., Liposomal lactoferrin as potential prevention and cure for COVID-19, Int J Res Health Sci,
doi:10.5530/ijrhs.8.1.3Siqueiros-Cendón, Arévalo-Gallegos, Iglesias-Figueroa, García-Montoya, Salazar-Martínez et al., Immunomodulatory effects of lactoferrin, Acta Pharmacol Sin,
doi:10.1038/aps.2013.200Sorensen, Sorensen, The proteins in whey, C R Trav Lab Carlsb Ser Chim
Vincent, Marshall, Dellinger, Simonson, Guntupalli et al., Talactoferrin in severe sepsis: results from the phase II/III Oral tAlactoferrin in Severe sepsis Trial, Crit Care Med,
doi:10.1097/CCM.0000000000001090Vitetta, Coulson, Beck, Gramotnev, Du et al., The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study, Complement Ther Med,
doi:10.1016/j.ctim.2012.12.006Wei, Yuan, Liu, Fu, Yu et al., Novel coronavirus infection in hospitalized infants under 1 year of age in China, JAMA,
doi:10.1001/jama.2020.2131Zhang, Liu, Potential interventions for novel coronavirus in China: a systematic review, J Med Virol,
doi:10.1002/jmv.25707Zhu, Zhang, Li, Yang, Song, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med,
doi:10.1056/NEJMoa2001017Zimecki, Właszczyk, Zagulski, Kübler, Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery, Arch Immunol Ther Exp (Warsz)
{ 'indexed': {'date-parts': [[2022, 8, 3]], 'date-time': '2022-08-03T11:54:34Z', 'timestamp': 1659527674707},
'reference-count': 46,
'publisher': 'Elsevier BV',
'issue': '3',
'license': [ { 'start': { 'date-parts': [[2020, 9, 1]],
'date-time': '2020-09-01T00:00:00Z',
'timestamp': 1598918400000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.com.au',
'clinicalkey.fr', 'elsevier.com', 'sciencedirect.com'],
'crossmark-restriction': True},
'published-print': {'date-parts': [[2020, 9]]},
'DOI': '10.1016/j.ijantimicag.2020.106118',
'type': 'journal-article',
'created': {'date-parts': [[2020, 7, 30]], 'date-time': '2020-07-30T01:59:56Z', 'timestamp': 1596074396000},
'page': '106118',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 75,
'title': 'Lactoferrin as potential preventative and adjunct treatment for COVID-19',
'prefix': '10.1016',
'volume': '56',
'author': [ { 'ORCID': 'http://orcid.org/0000-0001-9115-7799',
'authenticated-orcid': False,
'given': 'Raymond',
'family': 'Chang',
'sequence': 'first',
'affiliation': []},
{'given': 'Tzi Bun', 'family': 'Ng', 'sequence': 'additional', 'affiliation': []},
{'given': 'Wei-Zen', 'family': 'Sun', 'sequence': 'additional', 'affiliation': []}],
'member': '78',
'reference': [ { 'key': '10.1016/j.ijantimicag.2020.106118_bib0001',
'doi-asserted-by': 'crossref',
'first-page': '727',
'DOI': '10.1056/NEJMoa2001017',
'article-title': 'A novel coronavirus from patients with pneumonia in China, 2019',
'volume': '382',
'author': 'Zhu',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0002',
'doi-asserted-by': 'crossref',
'first-page': '3',
'DOI': '10.3892/ijmm.2020.4596',
'article-title': 'Towards effective COVID-19 vaccines: updates, perspectives and '
'challenges (review)',
'volume': '46',
'author': 'Calina',
'year': '2020',
'journal-title': 'Int J Mol Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0003',
'doi-asserted-by': 'crossref',
'first-page': '418',
'DOI': '10.1002/jmv.25681',
'article-title': 'Emerging coronaviruses: genome structure, replication, and pathogenesis',
'volume': '92',
'author': 'Chen',
'year': '2020',
'journal-title': 'J Med Virol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0004',
'doi-asserted-by': 'crossref',
'first-page': '282',
'DOI': '10.1139/o06-045',
'article-title': 'Interactions of lactoferrin with cells involved in immune function',
'volume': '84',
'author': 'Legrand',
'year': '2006',
'journal-title': 'Biochem Cell Biol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0005',
'doi-asserted-by': 'crossref',
'first-page': '752',
'DOI': '10.3390/molecules21060752',
'article-title': 'Antimicrobial activity of lactoferrin-related peptides and applications '
'in human and veterinary medicine',
'volume': '21',
'author': 'Bruni',
'year': '2016',
'journal-title': 'Molecules'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0006',
'doi-asserted-by': 'crossref',
'first-page': '558',
'DOI': '10.1080/22221751.2020.1736644',
'article-title': 'A tug-of-war between severe acute respiratory syndrome coronavirus 2 '
'and host antiviral defence: lessons from other pathogenic viruses',
'volume': '9',
'author': 'Fung',
'year': '2020',
'journal-title': 'Emerg Microbes Infect'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0007',
'first-page': '252',
'article-title': 'Lactoferrin: a general review',
'volume': '80',
'author': 'Levay',
'year': '1995',
'journal-title': 'Haematologica'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0008',
'first-page': '55',
'article-title': 'The proteins in whey',
'volume': '23',
'author': 'Sorensen',
'year': '1940',
'journal-title': 'C R Trav Lab Carlsb Ser Chim'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0009',
'doi-asserted-by': 'crossref',
'first-page': '510',
'DOI': '10.3891/acta.chem.scand.14-0510',
'article-title': 'Isolation of an iron-containing red protein from human milk',
'volume': '14',
'author': 'Johanson',
'year': '1960',
'journal-title': 'Acta Chem Scand'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0010',
'first-page': '4184',
'article-title': 'Protective influence of lactoferrin on mice infected with the '
'polycythemia-inducing strain of Friend virus complex',
'volume': '47',
'author': 'Lu',
'year': '1987',
'journal-title': 'Cancer Res'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0011',
'doi-asserted-by': 'crossref',
'first-page': '6997',
'DOI': '10.1007/s00253-015-6818-4',
'article-title': 'Antiviral activities of whey proteins',
'volume': '99',
'author': 'Ng',
'year': '2015',
'journal-title': 'Appl Microbiol Biotechnol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0012',
'doi-asserted-by': 'crossref',
'first-page': '666',
'DOI': '10.1016/j.jiac.2014.08.003',
'article-title': 'Lactoferrin for prevention of common viral infections',
'volume': '20',
'author': 'Wakabayashi',
'year': '2014',
'journal-title': 'J Infect Chemother'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0013',
'doi-asserted-by': 'crossref',
'first-page': 'e23710',
'DOI': '10.1371/journal.pone.0023710',
'article-title': 'Inhibition of SARS pseudovirus cell entry by lactoferrin binding to '
'heparan sulfate proteoglycans',
'volume': '6',
'author': 'Lang',
'year': '2011',
'journal-title': 'PLoS One'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0014',
'doi-asserted-by': 'crossref',
'first-page': '401',
'DOI': '10.1111/j.1462-5822.2004.00389.x',
'article-title': 'Herpes simplex virus: receptors and ligands for cell entry',
'volume': '6',
'author': 'Spear',
'year': '2004',
'journal-title': 'Cell Microbiol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0015',
'doi-asserted-by': 'crossref',
'first-page': '7206',
'DOI': '10.1111/j.1742-4658.2009.07400.x',
'article-title': 'Viral entry mechanisms: human papillomavirus and a long journey from '
'extracellular matrix to the nucleus',
'volume': '276',
'author': 'Sapp',
'year': '2009',
'journal-title': 'FEBS J'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0016',
'doi-asserted-by': 'crossref',
'unstructured': 'Andersen JH, Jenssen H, Sandvik K, Gutteberg TJ. Anti-HSV activity of '
'lactoferrin and lactoferricin is dependent on the presence of heparan '
'sulphate at the cell surface. J Med Virol200474:262–71. '
'doi:10.1002/jmv.20171.',
'DOI': '10.1002/jmv.20171'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0017',
'doi-asserted-by': 'crossref',
'first-page': '10162',
'DOI': '10.1074/jbc.M207879200',
'article-title': 'Identification of a lactoferrin-derived peptide possessing binding '
'activity to hepatitis C virus E2 envelope protein',
'volume': '278',
'author': 'Nozaki',
'year': '2003',
'journal-title': 'J Biol Chem'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0018',
'doi-asserted-by': 'crossref',
'first-page': '1055',
'DOI': '10.1016/S1357-2725(98)00066-1',
'article-title': 'Antiviral effect of bovine lactoferrin saturated with metal ions on '
'early steps of human immunodeficiency virus type 1 infection',
'volume': '30',
'author': 'Puddu',
'year': '1998',
'journal-title': 'Int J Biochem Cell Biol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0019',
'doi-asserted-by': 'crossref',
'unstructured': 'Vitetta L, Coulson S, Beck SL, Gramotnev H, Du S, Lewis S. The clinical '
'efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) '
'for the common cold: a double blind randomized study. Complement Ther '
'Med201321:164–71. doi:10.1016/j.ctim.2012.12.006.',
'DOI': '10.1016/j.ctim.2012.12.006'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0020',
'first-page': '121',
'article-title': 'Questionnaire survey on the subjective effects of a lactoferrin '
'supplement',
'volume': '9',
'author': 'Oda',
'year': '2012',
'journal-title': 'J Jpn Soc Complement Altern Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0021',
'doi-asserted-by': 'crossref',
'unstructured': 'Egashira M, Takayanagi T, Moriuchi M, Moriuchi H. Does daily intake of '
'bovine lactoferrin-containing products ameliorate rotaviral '
'gastroenteritis. Acta Paediatr200796:1242–4. '
'doi:10.1111/j.1651-2227.2007.00393.x.',
'DOI': '10.1111/j.1651-2227.2007.00393.x'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0022',
'doi-asserted-by': 'crossref',
'first-page': '1894',
'DOI': '10.1111/j.1440-1746.2007.04858.x',
'article-title': 'Effect of lactoferrin in patients with chronic hepatitis C: combination '
'therapy with interferon and ribavirin',
'volume': '22',
'author': 'Kaito',
'year': '2007',
'journal-title': 'J Gastroenterol Hepatol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0023',
'doi-asserted-by': 'crossref',
'first-page': '557',
'DOI': '10.1038/aps.2013.200',
'article-title': 'Immunomodulatory effects of lactoferrin',
'volume': '35',
'author': 'Siqueiros-Cendón',
'year': '2014',
'journal-title': 'Acta Pharmacol Sin'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0024',
'doi-asserted-by': 'crossref',
'first-page': '281',
'DOI': '10.1515/CCLM.1999.049',
'article-title': 'Lactoferrin: a multifunctional glycoprotein involved in the modulation '
'of the inflammatory process',
'volume': '37',
'author': 'Baveye',
'year': '1999',
'journal-title': 'Clin Chem Lab Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0025',
'doi-asserted-by': 'crossref',
'first-page': '1956',
'DOI': '10.2174/138161209788453202',
'article-title': 'Lactoferrin as a natural immune modulator',
'volume': '15',
'author': 'Actor',
'year': '2009',
'journal-title': 'Curr Pharm Des'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0026',
'doi-asserted-by': 'crossref',
'first-page': '1438',
'DOI': '10.3389/fimmu.2017.01438',
'article-title': 'Lactoferrin in a context of inflammation-induced pathology',
'volume': '8',
'author': 'Kruzel',
'year': '2017',
'journal-title': 'Front Immunol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0027',
'series-title': 'The ACCP/SCCM Consensus Conference Committee',
'first-page': '1644',
'article-title': 'Definitions for sepsis and organ failure and guidelines for the use of '
'innovative therapies in sepsis',
'volume': '101',
'author': 'Bone',
'year': '1992'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0028',
'doi-asserted-by': 'crossref',
'first-page': '1135',
'DOI': '10.1002/art.40071',
'article-title': 'Review: cytokine storm syndrome: looking toward the precision medicine '
'era',
'volume': '69',
'author': 'Behrens',
'year': '2017',
'journal-title': 'Arthritis Rheumatol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0029',
'doi-asserted-by': 'crossref',
'first-page': '67',
'DOI': '10.1177/1753425909105317',
'article-title': 'Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured '
'cells and in animal endotoxemia model',
'volume': '16',
'author': 'Kruzel',
'year': '2010',
'journal-title': 'Innate Immun'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0030',
'doi-asserted-by': 'crossref',
'first-page': '33',
'DOI': '10.1023/A:1006935908960',
'article-title': 'Lactoferrin protects gut mucosal integrity during endotoxemia induced '
'by lipopolysaccharide in mice',
'volume': '24',
'author': 'Kruzel',
'year': '2000',
'journal-title': 'Inflammation'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0031',
'article-title': 'Lactoferrin supplementation to prevent late-onset sepsis in preterm '
'infants: a meta-analysis',
'author': 'Razak',
'year': '2019',
'journal-title': 'Am J Perinatol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0032',
'doi-asserted-by': 'crossref',
'first-page': '706',
'DOI': '10.1097/CCM.0b013e3182741551',
'article-title': 'A phase 2 randomized, double-blind, placebo-controlled study of the '
'safety and efficacy of talactoferrin in patients with severe sepsis',
'volume': '41',
'author': 'Guntupalli',
'year': '2013',
'journal-title': 'Crit Care Med'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0033',
'doi-asserted-by': 'crossref',
'unstructured': 'Vincent JL, Marshall JC, Dellinger RP, Simonson SG, Guntupalli K, Levy '
'MM, et\xa0al. Talactoferrin in severe sepsis: results from the phase '
'II/III Oral tAlactoferrin in Severe sepsis Trial. Crit Care '
'Med201543:1832–8. doi:10.1097/CCM.0000000000001090.',
'DOI': '10.1097/CCM.0000000000001090'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0034',
'doi-asserted-by': 'crossref',
'first-page': '14451',
'DOI': '10.1128/JVI.79.22.14451-14456.2005',
'article-title': 'Murine coronavirus with an extended host range uses heparan sulfate as '
'an entry receptor',
'volume': '79',
'author': 'de Haan',
'year': '2005',
'journal-title': 'J Virol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0035',
'doi-asserted-by': 'crossref',
'unstructured': 'Milewska A, Zarebski M, Nowak P, Stozek K, Potempa J, Pyrc K. Human '
'coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment '
'to target cells. J Virol201488:13221–30. doi:10.1128/jvi.02078-14.',
'DOI': '10.1128/JVI.02078-14'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0036',
'doi-asserted-by': 'crossref',
'unstructured': 'Burckhardt CJ, Greber UF.Virus movements on the plasma membrane support '
'infection and transmission between cells. PLoS Pathog20095:e1000621. '
'doi:10.1371/journal.ppat.1000621.',
'DOI': '10.1371/journal.ppat.1000621'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0037',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.cell.2020.02.052',
'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a '
'clinically proven protease inhibitor',
'volume': '181',
'author': 'Hoffmann',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0038',
'doi-asserted-by': 'crossref',
'first-page': '8',
'DOI': '10.5530/ijrhs.8.1.3',
'article-title': 'Liposomal lactoferrin as potential prevention and cure for COVID-19',
'volume': '8',
'author': 'Serrano',
'year': '2020',
'journal-title': 'Int J Res Health Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0039',
'doi-asserted-by': 'crossref',
'first-page': '1033',
'DOI': '10.1016/S0140-6736(20)30628-0',
'article-title': 'COVID-19: consider cytokine storm syndromes and immunosuppression',
'volume': '395',
'author': 'Mehta',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0040',
'first-page': '97',
'article-title': 'Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha '
'levels in mice subjected to surgery',
'volume': '46',
'author': 'Zimecki',
'year': '1998',
'journal-title': 'Arch Immunol Ther Exp (Warsz)'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0041',
'doi-asserted-by': 'crossref',
'first-page': '1985',
'DOI': '10.3390/ijms18091985',
'article-title': 'Lactoferrin: a natural glycoprotein involved in iron and inflammatory '
'homeostasis',
'volume': '18',
'author': 'Rosa',
'year': '2017',
'journal-title': 'Int J Mol Sci'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0042',
'doi-asserted-by': 'crossref',
'first-page': '1717',
'DOI': '10.1248/bpb.28.1717',
'article-title': "Liposomalization of lactoferrin enhanced it's anti-inflammatory effects "
'via oral administration',
'volume': '28',
'author': 'Ishikado',
'year': '2005',
'journal-title': 'Biol Pharm Bull'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0043',
'doi-asserted-by': 'crossref',
'first-page': '131',
'DOI': '10.1016/j.pedneo.2020.03.001',
'article-title': 'Clinical characteristics of novel coronavirus disease 2019 (COVID-19) '
'in newborns, infants and children',
'volume': '61',
'author': 'Hong',
'year': '2020',
'journal-title': 'Pediatr Neonatol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0044',
'doi-asserted-by': 'crossref',
'first-page': '1313',
'DOI': '10.1001/jama.2020.2131',
'article-title': 'Novel coronavirus infection in hospitalized infants under 1 year of age '
'in China',
'volume': '323',
'author': 'Wei',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0045',
'doi-asserted-by': 'crossref',
'first-page': '199',
'DOI': '10.1007/s004300050093',
'article-title': 'Inhibition of poliovirus type 1 infection by iron-, manganese- and '
'zinc-saturated lactoferrin',
'volume': '187',
'author': 'Marchetti',
'year': '1999',
'journal-title': 'Med Microbiol Immunol'},
{ 'key': '10.1016/j.ijantimicag.2020.106118_bib0046',
'doi-asserted-by': 'crossref',
'first-page': '479',
'DOI': '10.1002/jmv.25707',
'article-title': 'Potential interventions for novel coronavirus in China: a systematic '
'review',
'volume': '92',
'author': 'Zhang',
'year': '2020',
'journal-title': 'J Med Virol'}],
'container-title': 'International Journal of Antimicrobial Agents',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303010?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920303010?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2021, 3, 27]],
'date-time': '2021-03-27T08:46:14Z',
'timestamp': 1616834774000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920303010'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 9]]},
'references-count': 46,
'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2020, 9]]}},
'alternative-id': ['S0924857920303010'],
'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.106118',
'relation': {},
'ISSN': ['0924-8579'],
'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Microbiology (medical)', 'General Medicine'],
'container-title-short': 'International Journal of Antimicrobial Agents',
'published': {'date-parts': [[2020, 9]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Lactoferrin as potential preventative and adjunct treatment for COVID-19',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'International Journal of Antimicrobial Agents',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.106118',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. '
'All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}],
'article-number': '106118'}
